ANTIBODY AGAINST TIE-2 AND ITS USE Russian patent published in 2023 - IPC C07K16/28 A61K39/395 C12N15/09 C12N5/10 A61P9/14 A61P35/00 

Abstract RU 2795455 C2

FIELD: biotechnology.

SUBSTANCE: following are presented: an antibody or its antigen-binding fragment that binds to TIE-2 tyrosine-protein kinase receptor and a method for their production, a nucleic acid encoding an antibody or its antigen-binding fragment, an expression vector, a cell transformed with an expression vector to obtain an antibody or its antigen-binding fragment. Also a composition is provided for preventing or treating an angiogenesis-related disease, a composition for stabilizing blood vessels, a composition for diagnosing an angiogenesis-related disease, a composition for preventing or treating cancer, a composition for preventing or treating a tumor, and the use of a composition containing a pharmaceutically effective the amount of the antibody or antigen-binding fragment thereof.

EFFECT: invention makes it possible to obtain an antibody or its antigen-binding fragment that binds to TIE-2 tyrosine-protein kinase receptor, as well as compositions for the prevention or treatment of an angiogenesis-related disease.

16 cl, 18 dwg, 4 tbl, 13 ex

Similar patents RU2795455C2

Title Year Author Number
PROGRAMMED CELL DEATH (PD-1) PROTEIN-1 ANTIBODIES AND USE THEREOF 2017
  • Park, Jae Eun
  • Kim, Soo Young
  • Lee, Hyun Mi
  • Lee, Si Hyung
  • Lee, Hyun Kyung
  • Kim, Hye-Nan
  • Youn, Jin Chul
  • Park, Bum-Chan
  • Lim, Jung Chae
  • Cho, Young-Gyu
  • Park, Young Woo
RU2725950C1
ANTIBODY AGAINST ANG2 AND ITS USE 2020
  • Nam, Ju Ryoung
  • Byun, Sang Soon
  • Ko, Jongil
  • Kim, Do-Yun
  • Lee, Joo Hyoung
  • Ha, Jung Min
  • Park, Cheonho
  • Lee, Eun-Ah
  • Lee, Weon Sup
  • Yoo, Jin-San
RU2788088C1
ANTIBODIES AGAINST VISTA AND APPLICATION THEREOF 2018
  • Lee, Youngae
  • Byun, Sang Soon
  • Ha, Jung Min
  • Ahn, Sungho
  • Oh, Keunhee
  • Lee, Weon Sup
  • Park, Mi Ju
  • Lee, Eun Hee
  • Kim, Do-Yun
  • Yoo, Jin-San
RU2750723C1
ANTIBODIES AGAINST LIGAND-1 PROGRAMMED DEATH (PD-L1) AND APPLICATION THEREOF 2017
  • Pak, Che Yn
  • Tsoj, Su A
  • Li, Chisu
  • Li, Khen Mi
  • Li, Si Khen
  • Pek, Ki Son
  • Kim, En Chul
  • Pak, Bum-Chan
  • Lim, Chon Chkhe
  • Cho, Yun-Giu
  • Pak, Yun U
RU2721582C1
ANTIBODIES TO HUMAN INTERLEUKIN-2 AND THEIR APPLICATION 2018
  • Surh, Charles D.
  • Lee, Jun-Young
RU2745451C1
ANTI-DR5 ANTIBODY AND USE THEREOF 2018
  • Doh Hyounmie
  • Lee Dongsop
  • Lee Hanyoung
  • Kim Yoojin
  • Han Kyungmi
  • Jung Eunee
  • Kim Donghyeon
  • Song Dongsup
  • Shin Kum-Joo
  • Woo Soyon
RU2735956C1
ANTIBODIES AGAINST A5 REPRESENTATIVE OF 19 FAMILY WITH SIMILARITY OF SEQUENCES AND THEIR APPLICATION METHOD 2019
  • Kim, Bongcheol
  • Kim, Wonkyum
  • Kim, Dong Sik
  • Lee, Jae-Keun
  • Yoon, Jeongwon
  • Chung, Junho
  • Jin, Junyeong
RU2785436C2
ANTIBODY AGENTS SPECIFIC TO HUMAN CD19, AND THEIR APPLICATIONS 2016
  • Liu, Hong
  • Lu, Jingwei
  • Yang, Zhiyuan
  • Long, Li
  • Cheng, Neal
RU2773317C2
COMPOSITION FOR PREVENTION AND TREATMENT OF SKIN DISEASE CONTAINING SUBSTANCE SPECIFICALLY BINDING WITH VIMENTINE DERIVATIVE PEPTIDE 2018
  • Kim Yoon-Won
  • Park Sungman
  • Kim Min Soo
RU2751486C1
NEW MONOCLONAL ANTIBODIES TO PROGRAMMED CELL DEATH 1 (PD-1) PROTEIN 2016
  • Zheng, Yong
  • Li, Jing
  • Gololobov, Gennady
  • Zhang, Xinhua
  • Yang, Baotian
  • Tang, Zhewei
  • Li, Dong
  • Xu, Jianqing
  • Wang, Zhuozhi
RU2757316C2

RU 2 795 455 C2

Authors

Lee, Eun-Ah

Park, Beom Yong

Kang, Nu Ri

Park, Cheonho

Lee, Youngae

Kim, Do-Yun

Lee, Weon Sup

Yoo, Jin-San

Dates

2023-05-03Published

2020-08-14Filed